GlassScriptPhysician profile
Marc Nicholes
NPI 1073288767
$2,307.56
in general payments reported to CMS, 2019-2025
13 companies · $1,250 in 2025
The $1,250 reported for 2025 was more than what 90% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $167 · 2023: $210 · 2024: $680 · 2025: $1,250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,141.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,140.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $834.53 | 2022-2025 | Gmrs, Aequalis Perform Reversed, Variax |
| Zimmer Biomet Holdings, INC. | $328.88 | 2023-2025 | Persona, Xtrafix |
| Vericel Corporation | $248.71 | 2024-2025 | Maci |
| Bioventus LLC | $242.56 | 2024-2025 | Durolane, Exogen Ultrasound Bone Healing System |
| Orthofix Medical, INC. | $177.46 | 2024-2025 | Truelok, Ankle Hindfoot Nailing System |
| Orthalign INC | $94.59 | 2022 | |
| Axogen | $87.26 | 2025 | |
| Si-Bone, INC. | $74.55 | 2023-2024 | |
| Sanara Medtech INC. | $69.27 | 2025 | Celleraterx |
| Kci USA, INC. | $56.78 | 2022-2023 | Prevena, V.A.C. Veraflo |
| Pacira Pharmaceuticals Incorporated | $44.78 | 2022-2025 | Exparel |
| Rattan and Associates | $31.37 | 2025 | |
| Csl Behring | $16.82 | 2023 | Kcentra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Nicholes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.